Story of ISCO Clinical Trial Patient Kevin Weeks

Kevin Weeks, a Parkinson’s disease patient who underwent neural stem cell treatment in an International Stem Cell Corporation (ISCO) clinical trial, recently issued a video thanking the neurosurgeons who performed his life changing operation. At 63, real estate icon Kevin Weeks was the picture of good health. He exercised regularly, ate healthy, and didn’t smoke. […]

Read More >>

International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson’s Disease Clinical Trial

CARLSBAD, CA – International Stem Cell Corporation (OTCQB: ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today the positive six months interim results of the first cohort of Parkinson’s disease (PD) patients receiving 30 million ISC-hpNSC cells in the ongoing clinical study. All patients in the first cohort […]

Read More >>